missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
Streptozocin is used to treat pancreatic islet cell tumors, including malignant insulinoma. It is also used to induce Type 1 diabetes in animals for medical research purposes.
- An N-nitroso-containing compound that acts as a nitric oxide donor in pancreatic islets
- Induces death of insulin-secreting cells, producing an animal model of diabetes
- Potent DNA methylating agent that induces chromosomal breakage
- Cytotoxic to neuroendocrine tumor cell lines that express the GLUT2 glucose transporter
Specifications
Specifications
| Physical Form | Powder |
| Melting Point | 121°C (decomposition) (literature) |
| Extinction Coefficient | EmM (228nm): 6.36 (ethanol) |
| Quantity | 500 mg |
| Solubility Information | Soluble in water (50mg/mL, clear to slightly hazy, light yellow solution) and ethanol. |
| Formula Weight | 265.22 |
| Percent Purity | ∼75% α-anomer basis, ≥97% |
Safety and Handling
Product Identifier
- Streptozotocin
- Danger
- Acute toxicity Category 4
- Carcinogenicity Category 1A
- Germ cell mutagenicity Category 1A
- Reproductive toxicity Category 1A
- H312-Harmful in contact with skin.
- H332-Harmful if inhaled.
- H340-May cause genetic defects.
- H350-May cause cancer.
- H360-May damage fertility or the unborn child.
- P261-Avoid breathing dust/fume/gas/mist/vapours/spray.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P304+P340-IF INHALED: Remove person to fresh air and keep comfortable for breathing.
- P321-Specific treatment (see on this label).
- P405-Store locked up.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contains : Streptozotocin
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?